|
CA3030772A1
|
|
Processes for making, and methods of using, glycopyrronium compounds
|
|
WO2018022797A1
|
|
Dermatological formulations of 2-(2-ethoxy-2-oxoethyl)(methyl)amino-2-oxoethyl 5-(tetradecyloxy)furan-2-carboxylate
|
|
KR20170113590A
|
|
Synthesis method for the preparation of 2 - ((2-ethoxy-2-oxoethyl) (methyl) amino) -2-oxoethyl 5-tetradecyloxy)
|
|
CA2975922A1
|
|
Synthetic process for preparing 2-furoic acid derivatives
|
|
EP3200863A1
|
|
Device for dispensing a drug
|
|
CA2957297A1
|
|
Hyperhidrosis treatment
|
|
US2016052879A1
|
|
Process for production of glycopyrronium tosylate
|
|
US2014371290A1
|
|
Glycopyrrolate salts
|
|
KR20160081989A
|
|
Glycopyrrolate salts
|
|
KR20150030763A
|
|
Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
|
|
US2013211101A1
|
|
Crystalline glycopyrrolate tosylate
|
